For instance, co-mutations in genes like TP53, RB1, NF1, ARID1A, BRCA1, and PTEN are associated with worse outcomes in patients with EGFR-mutant NSCLC [21]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.